Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2007-04-30 | Dr. Blaschke has served on the faculty of Stanford University since 1974 and is Professor of Medicine and Molecular Pharmacology. |
| 2008-04-29 | Dr. Blaschke has served on the faculty of Stanford University since 1974 and is Professor of Medicine and Molecular Pharmacology. |
| 2010-04-29 | Dr. Blaschke's medical and scientific expertise and pharmaceutical industry experience as relates to drug development are among the qualifications he brings to the Board and his service as a Director of the Company. |
| 2011-04-28 | Dr. Blaschke’s medical and scientific expertise and pharmaceutical industry experience as relates to drug development are among the qualifications he brings to the Board and his service as a Director of the Company. |
| 2012-04-26 | Dr. Blaschke is Professor of Medicine and Molecular Pharmacology at Stanford University and has served as Vice President of Methodology and Science at Pharsight Corporation. |
| 2013-04-29 | Dr. Blaschke is Professor of Medicine and Molecular Pharmacology and has served as Vice President of Methodology and Science at Pharsight Corporation. |
| 2014-04-23 | Dr. Blaschke is Professor of Medicine and Molecular Pharmacology (Emeritus) at Stanford University School of Medicine and has served as an independent consultant to pharmaceutical companies. |
| 2015-04-22 | Dr. Blaschke has served on the faculty of Stanford University and is Professor of Medicine and Molecular Pharmacology (Emeritus) at the Stanford University School of Medicine. He is currently a senior program officer, Global Health Discovery and Translational Science at the Bill and Melinda Gates Foundation. |
| 2016-04-28 | Dr. Blaschke is Professor of Medicine and Molecular Pharmacology and has served as an independent consultant to pharmaceutical and biotechnology companies. |
| 2017-04-27 | Dr. Blaschke has served on the faculty of Stanford University since 1974 and is Professor of Medicine and Molecular Pharmacology (Emeritus) at the Stanford University School of Medicine. |
| 2018-04-27 | Dr. Blaschke’s medical and scientific expertise and pharmaceutical industry experience as relates to drug development are among the qualifications he brings to the Board and his service as a Director of the Company. |
| 2019-04-26 | Dr. Blaschke’s medical and scientific expertise and pharmaceutical industry experience relating to drug development are among the qualifications he brings to the Board. |
| 2020-04-27 | Dr. Blaschke’s medical and scientific expertise and pharmaceutical industry experience relating to drug development are among the qualifications he brings to the Board. |
| 2021-04-23 | Dr. Blaschke is Professor of Medicine and Molecular Pharmacology and has served as Vice President of Methodology and Science at Pharsight Corporation. |
| 2022-04-25 | Dr. Blaschke holds his M.D. degree from Columbia University and a B.S. in Mathematics from the University of Denver. |
| 2023-04-27 | Dr. Blaschke holds his M.D. degree from Columbia University and a B.S. in Mathematics from the University of Denver. Dr. Blaschke’s medical and scientific expertise and pharmaceutical industry experience relating to drug development are among the qualifications he brings to our Board of Directors. |
| 2024-08-12 | Dr. Blaschke holds his M.D. degree from Columbia University and a B.S. in Mathematics from the University of Denver. |
Data sourced from SEC filings. Last updated: 2026-02-03